Media Summary: In this video, Michael Heuser, MD, of Hannover Medical School, Hanover, Germany, explains the process of how measurable ... Watch the full course and our most up-to-date content here: Create a free account to track ... Dr Richard Dillon, Department of Medical & Molecular Genetics, King's College is a Clinical Senior Lecturer in Cancer Genetics in ...

How To Utilize Mrd Testing For Aml - Detailed Analysis & Overview

In this video, Michael Heuser, MD, of Hannover Medical School, Hanover, Germany, explains the process of how measurable ... Watch the full course and our most up-to-date content here: Create a free account to track ... Dr Richard Dillon, Department of Medical & Molecular Genetics, King's College is a Clinical Senior Lecturer in Cancer Genetics in ... Alexander Perl, MD, University of Pennsylvania, Philadelphia, PA, discusses the clinical meaning of measurable residual disease ... Here, Michael Heuser, MD, of Hannover Medical School, Hanover, Germany, gives a background on the clinical application of ... Christopher Hourigan, MD, DPhil, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, reflects on ...

Sylvie Freeman, MBChB, MRCP, DPhil, FRCPath, University of Birmingham, Birmingham, UK, comments on the value of ... Dr Christopher Hourigan presents results at the 2019 European Hematology Association (EHA) Annual Meeting from a study ... Laura Dillon, PhD, FACMG, National Institutes of Health, Bethesda, MD, talks on the Harry Erba, MD, PhD, professor of medicine, director, University of Alabama (UAB) Hematologic Malignancy Program, UAB ... Daniel Pollyea, MD, MS, University of Colorado, Denver, CO, briefly discusses the potential Experts expand on the practical and clinical

A panel of experts considers how minimal residual disease ( In this video, Gail Roboz, MD, Weill Cornell Medicine, New York City, NY, discusses the ongoing Recorded on September 14th, 2023 as part of the Adult Jacqueline Cloos, PhD, Amsterdam University Medical Center, Amsterdam, The Netherlands, gives an update on the role of ... Alessandro Isidori, MD, PhD, Marche Nord Hospital, Pesaro, Italy, discusses the possible implications for measurable residual ...

Photo Gallery

How to utilize MRD testing for AML
What is MRD and why is testing for it useful in AML? #AML
Clinical Use of Molecular MRD Testing in AML
Methods to evaluate MRD in AML
The clinical application of MRD testing in AML
MRD testing in AML: the next steps in 2019
How can MRD guide treatment of AML?
Flow-based MRD versus other MRD detection techniques in AML
Intervention for AML patients with MRD can result in improved survival
Know AML | Measurable Residual Disease
Updates on the use of molecular monitoring to detect MRD in AML
Using MRD to Guide Therapy in AML
View Detailed Profile
How to utilize MRD testing for AML

How to utilize MRD testing for AML

In this video, Michael Heuser, MD, of Hannover Medical School, Hanover, Germany, explains the process of how measurable ...

What is MRD and why is testing for it useful in AML? #AML

What is MRD and why is testing for it useful in AML? #AML

Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversity Create a free account to track ...

Clinical Use of Molecular MRD Testing in AML

Clinical Use of Molecular MRD Testing in AML

Dr Richard Dillon, Department of Medical & Molecular Genetics, King's College is a Clinical Senior Lecturer in Cancer Genetics in ...

Methods to evaluate MRD in AML

Methods to evaluate MRD in AML

Alexander Perl, MD, University of Pennsylvania, Philadelphia, PA, discusses the clinical meaning of measurable residual disease ...

The clinical application of MRD testing in AML

The clinical application of MRD testing in AML

Here, Michael Heuser, MD, of Hannover Medical School, Hanover, Germany, gives a background on the clinical application of ...

MRD testing in AML: the next steps in 2019

MRD testing in AML: the next steps in 2019

Measurable residual disease (

How can MRD guide treatment of AML?

How can MRD guide treatment of AML?

Christopher Hourigan, MD, DPhil, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, reflects on ...

Flow-based MRD versus other MRD detection techniques in AML

Flow-based MRD versus other MRD detection techniques in AML

Sylvie Freeman, MBChB, MRCP, DPhil, FRCPath, University of Birmingham, Birmingham, UK, comments on the value of ...

Intervention for AML patients with MRD can result in improved survival

Intervention for AML patients with MRD can result in improved survival

Dr Christopher Hourigan presents results at the 2019 European Hematology Association (EHA) Annual Meeting from a study ...

Know AML | Measurable Residual Disease

Know AML | Measurable Residual Disease

Measurable residual disease (

Updates on the use of molecular monitoring to detect MRD in AML

Updates on the use of molecular monitoring to detect MRD in AML

Laura Dillon, PhD, FACMG, National Institutes of Health, Bethesda, MD, talks on the

Using MRD to Guide Therapy in AML

Using MRD to Guide Therapy in AML

Harry Erba, MD, PhD, professor of medicine, director, University of Alabama (UAB) Hematologic Malignancy Program, UAB ...

The potential use of multi-gene molecular MRD testing in AML

The potential use of multi-gene molecular MRD testing in AML

Daniel Pollyea, MD, MS, University of Colorado, Denver, CO, briefly discusses the potential

MRD Assessment and its Clinical Implications in AML

MRD Assessment and its Clinical Implications in AML

Experts expand on the practical and clinical

Future Directions for MRD Testing in ALL

Future Directions for MRD Testing in ALL

A panel of experts considers how minimal residual disease (

MRD assessment in AML: challenges and evolving clinical impact

MRD assessment in AML: challenges and evolving clinical impact

In this video, Gail Roboz, MD, Weill Cornell Medicine, New York City, NY, discusses the ongoing

MRD testing in AML

MRD testing in AML

... responses in in

What You Need to Know About MRD for AML: The Basics | Dr. Tian Zhang #AML

What You Need to Know About MRD for AML: The Basics | Dr. Tian Zhang #AML

Recorded on September 14th, 2023 as part of the Adult

Molecular diagnosis and MRD monitoring in AML

Molecular diagnosis and MRD monitoring in AML

Jacqueline Cloos, PhD, Amsterdam University Medical Center, Amsterdam, The Netherlands, gives an update on the role of ...

The possibility of using MRD status to drive treatment in AML

The possibility of using MRD status to drive treatment in AML

Alessandro Isidori, MD, PhD, Marche Nord Hospital, Pesaro, Italy, discusses the possible implications for measurable residual ...